» Articles » PMID: 33502730

Analysis of Clinical and Genetic Characteristics of Chinese Children with Congenital Hyperinsulinemia That is Spontaneously Relieved

Overview
Journal Endocrine
Specialty Endocrinology
Date 2021 Jan 27
PMID 33502730
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aimed to analyze the clinical and genetic characteristics of Chinese children with congenital hyperinsulinemia (CHI) that is spontaneously relieved.

Methods: The patient group comprised 200 children with CHI that were treated at the Beijing Children's Hospital from January 2006 to December 2018. The patients were divided into two groups according to their prognosis: the spontaneous remission group (n = 92) and the nonspontaneous remission group (n = 108). The clinical characteristics, pathogenic genes, diagnosis and treatment process, and follow-up data of both groups were analyzed retrospectively.

Results: Of the 200 children with CHI, 92 achieved spontaneous remission. The age of spontaneous remission was between one month and nine years, and 47 of the children were relieved before the age of one year. The median age of onset was 85 days (range: 1-2825 days) in the spontaneous remission group and 2 days (range: 1-210 days) in the nonspontaneous remission group (P < 0.05). The mean birth weight was 3.44 ± 0.76 kg for the spontaneous remission group and 3.95 ± 0.75 kg for the nonspontaneous remission group (P < 0.05). Of the 92 children in the spontaneous remission group, 65 were treated with diazoxide with effective rate of 81.5% (53/65). In 12 cases in which diazoxide treatment failed, octreotide was used with an effective rate of 83.3% (10/12). Of the 108 children in the nonspontaneous remission group, 88 were treated with diazoxide with an effective rate of 43.2 % (38/88), and 29 children were treated with octreotide with an effective rate of 48.28% (14/29). Of the 30 children in the spontaneous remission group that underwent mutation analysis of CHI-related pathogenic genes, 10 children (10/30, 33.3%) carried mutations. Of the 48 children in the nonspontaneous remission group that underwent mutation analysis of CHI-related pathogenic genes, 37 children (37/48, 77.1%) were found to carry mutations. All of the differences in the indices mentioned above were statistically significant.

Conclusions: The rate of spontaneous remission of CHI was significantly higher in children with late age of CHI onset, light birth weight, effective diazoxide treatment, and no common pathogenic gene mutations. Spontaneous remission was also possible for a small number of children that carried mutations in the ABCC and KCNJ11 genes and in whom diazoxide treatment failed.

Citing Articles

A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life.

Vedovato N, Salguero M, Greeley S, Yu C, Philipson L, Ashcroft F Diabetologia. 2024; 67(5):940-951.

PMID: 38366195 PMC: 10954967. DOI: 10.1007/s00125-024-06103-w.


Genotype-phenotype correlation in Taiwanese children with diazoxide-unresponsive congenital hyperinsulinism.

Lee C, Tsai W, Chang C, Chen P, Fann C, Chang H Front Endocrinol (Lausanne). 2023; 14:1283907.

PMID: 38033998 PMC: 10687152. DOI: 10.3389/fendo.2023.1283907.


Innovation in Hyperinsulinemia Diagnostics with ANN-L() Models.

Rankovic N, Rankovic D, Lukic I Diagnostics (Basel). 2023; 13(4).

PMID: 36832286 PMC: 9955502. DOI: 10.3390/diagnostics13040798.


A Novel Approach of Determining the Risks for the Development of Hyperinsulinemia in the Children and Adolescent Population Using Radial Basis Function and Support Vector Machine Learning Algorithm.

Lukic I, Rankovic N, Savic N, Rankovic D, Popov Z, Vujic A Healthcare (Basel). 2022; 10(5).

PMID: 35628058 PMC: 9141748. DOI: 10.3390/healthcare10050921.


Risk Assessment and Determination of Factors That Cause the Development of Hyperinsulinemia in School-Age Adolescents.

Lukic I, Savic N, Simic M, Rankovic N, Rankovic D, Lazic L Medicina (Kaunas). 2022; 58(1).

PMID: 35056318 PMC: 8778979. DOI: 10.3390/medicina58010009.

References
1.
De Leon D, Stanley C . Determination of insulin for the diagnosis of hyperinsulinemic hypoglycemia. Best Pract Res Clin Endocrinol Metab. 2013; 27(6):763-9. PMC: 4141553. DOI: 10.1016/j.beem.2013.06.005. View